Page 33 - FLIPBOOK
P. 33
Cardiovascular Risk Profile in PCa Patients Treated with GnRH Agonists versus
Antagonists: An Italian Real-World Analysis
Kaplan-Meier survival curves of incidence of CV events in GnRH agonists and antagonist-treated patients
at 5 years considering
Overall cohort Sub-cohort of patients without previous CV events
V.Perrone, Therapeutic and Clinical Risk Management 2020 16; 393—401
